JP2006527751A5 - - Google Patents

Download PDF

Info

Publication number
JP2006527751A5
JP2006527751A5 JP2006516435A JP2006516435A JP2006527751A5 JP 2006527751 A5 JP2006527751 A5 JP 2006527751A5 JP 2006516435 A JP2006516435 A JP 2006516435A JP 2006516435 A JP2006516435 A JP 2006516435A JP 2006527751 A5 JP2006527751 A5 JP 2006527751A5
Authority
JP
Japan
Prior art keywords
ethyl
formula
thio
hydroxyphenyl
phenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006516435A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006527751A (ja
Filing date
Publication date
Priority claimed from GBGB0314260.1A external-priority patent/GB0314260D0/en
Application filed filed Critical
Publication of JP2006527751A publication Critical patent/JP2006527751A/ja
Publication of JP2006527751A5 publication Critical patent/JP2006527751A5/ja
Withdrawn legal-status Critical Current

Links

JP2006516435A 2003-06-19 2004-06-16 ラセミ体の2−{[2−(4−ヒドロキシフェニル)エチル]チオ}−3−[4−(2−{4−[(メチルスルホニル)オキシ]フェノキシ}エチル)フェニル]プロパン酸を製造するための方法 Withdrawn JP2006527751A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314260.1A GB0314260D0 (en) 2003-06-19 2003-06-19 Therapeutic agents
PCT/GB2004/002599 WO2004113285A1 (en) 2003-06-19 2004-06-16 Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid

Publications (2)

Publication Number Publication Date
JP2006527751A JP2006527751A (ja) 2006-12-07
JP2006527751A5 true JP2006527751A5 (cg-RX-API-DMAC7.html) 2007-07-05

Family

ID=27636892

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006516435A Withdrawn JP2006527751A (ja) 2003-06-19 2004-06-16 ラセミ体の2−{[2−(4−ヒドロキシフェニル)エチル]チオ}−3−[4−(2−{4−[(メチルスルホニル)オキシ]フェノキシ}エチル)フェニル]プロパン酸を製造するための方法

Country Status (14)

Country Link
US (1) US7429675B2 (cg-RX-API-DMAC7.html)
EP (1) EP1638929A1 (cg-RX-API-DMAC7.html)
JP (1) JP2006527751A (cg-RX-API-DMAC7.html)
KR (1) KR20060010840A (cg-RX-API-DMAC7.html)
CN (1) CN1835918A (cg-RX-API-DMAC7.html)
AU (1) AU2004249487A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0411450A (cg-RX-API-DMAC7.html)
CA (1) CA2529252A1 (cg-RX-API-DMAC7.html)
GB (1) GB0314260D0 (cg-RX-API-DMAC7.html)
IL (1) IL172376A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA05013716A (cg-RX-API-DMAC7.html)
NO (1) NO20055883L (cg-RX-API-DMAC7.html)
WO (1) WO2004113285A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200509944B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
CN1319938C (zh) 2002-06-20 2007-06-06 阿斯特拉曾尼卡有限公司 治疗胰岛素抵抗的邻位取代的苯甲酸衍生物
GB0314075D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0427524D0 (en) 2004-12-16 2005-01-19 Astrazeneca Ab Chemical process
KR101558005B1 (ko) * 2007-03-08 2015-10-06 알비레오 에이비 2-치환-3-페닐프로피온산 유도체 및 염증성 장 질환 치료에서의 그의 용도
FR2986804A1 (fr) * 2012-02-09 2013-08-16 Servier Lab Procede de synthese enzymatique de l'acide (7s) 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene 7-carboxylique ou de ses esters, et application a la synthese de l'ivabradine et de ses sels

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61197530A (ja) 1985-02-25 1986-09-01 Mitsubishi Gas Chem Co Inc ラセミ化法
DE3683512D1 (de) 1985-02-25 1992-03-05 Mitsubishi Gas Chemical Co Verfahren zur optischen isomerisierung von optisch aktiver aminosaeure und verfahren zur herstellung von optisch aktiver aminosaeure.
TW472047B (en) 1994-02-04 2002-01-11 Merck & Co Inc Process for making HIV protease inhibitors
SE9801992D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
MA26634A1 (fr) 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE0104333D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents

Similar Documents

Publication Publication Date Title
JP2007505891A5 (cg-RX-API-DMAC7.html)
JP2005538950A5 (cg-RX-API-DMAC7.html)
JP2005539045A5 (cg-RX-API-DMAC7.html)
JP2012515142A5 (cg-RX-API-DMAC7.html)
US20070287839A1 (en) Novel process for the preparation of esomeprazole and salts thereof
JP2006527751A5 (cg-RX-API-DMAC7.html)
JP2020073474A5 (cg-RX-API-DMAC7.html)
JP2005500322A (ja) 3−フェニルイソセリンの製法
WO2008106900A1 (en) Method of manufacturing (3r, 4s) -1- (4-fluorophenyl) -3- [ (3s) -3- (4 -fluorophenyl) -3-hydroxypropyl) ] -4- (4-hyd roxyphenyl) -2-azetidinone
CN1662484A (zh) 制备(r)芳氧基丙酸酯衍生物的方法
JP2007524614A (ja) α−(フェノキシ)フェニル酢酸誘導体の分割
KR20100035597A (ko) 몬테루카스트 나트륨염의 제조방법
US7429675B2 (en) Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid
JP7109056B2 (ja) S-icaリボシルホモシステインの製造方法
CN102093284B (zh) 富集哌啶-2-甲酰苯胺类旋光化合物的方法
CN101058588A (zh) 一种合成阿德福韦的方法
JP2013173677A (ja) (1r,2s)−1−アミノ−2−ビニルシクロプロパンカルボン酸エステルの製造法
JP2005538126A5 (cg-RX-API-DMAC7.html)
JP2007506794A5 (cg-RX-API-DMAC7.html)
JP2014520796A5 (cg-RX-API-DMAC7.html)
JP2008105970A (ja) ジヒドロキノリン誘導体の製造方法及びその中間体
JP2006509022A5 (cg-RX-API-DMAC7.html)
JP2006516588A5 (cg-RX-API-DMAC7.html)
JP2005511786A6 (ja) 鏡像体的に富化されたチオ化合物の製造法
JP2005511786A (ja) 鏡像体的に富化されたチオ化合物の製造法